Skip to main content
Full access
Letters
Published Online: 1 April 2015

Symptom Severity and Readiness to Quit Among Hospitalized Smokers With Mental Illness

To the Editor: Beliefs prevail that mental illness and greater symptom severity are major barriers to interest in and success with quitting smoking (1). Yet recent studies have found that 80%−89% of smokers hospitalized for psychiatric treatment intend to quit smoking within the next six months (2,3).
Smoking contributes to and exacerbates numerous general medical conditions, and persons with mental illness report poorer health than the general population (4). Little is known regarding the role of health and intentions to quit smoking among individuals with acute mental illness.
In a sample of 956 adult daily smokers recruited during a smoke-free psychiatric hospitalization (2009–2013), we examined the association of psychiatric and general medical symptom severity with tobacco dependence and readiness to quit. The study was approved by an institutional review board and conducted at three San Francisco Bay Area hospitals. Participants provided informed consent. The following measures were completed during hospitalization by interview: mental and physical functioning (SF-12); psychiatric symptom severity (BASIS-24); and cigarette dependence (Fagerström Test for Cigarette Dependence [FTCD]). Confidence, desire, and perceived difficulty with quitting and smoking stage of change were also assessed.
With a 73% recruitment rate, the sample was representative of patients at participating hospitals: male, 51%; non-Hispanic Caucasian, 48%; African American, 23%; other race-ethnicity, 29%; and employed, 21%. Most (66%) had co-occurring disorders: substance use disorder, 61%; bipolar disorder, 32%; nonaffective psychosis, 27%; PTSD, 39%; unipolar depression, 27%; and ADHD, 28%. Before hospitalization, participants averaged 17±10 cigarettes per day and had smoked for 19±14 years, with moderate dependence (FTCD score, 5±2 out of possible 10); 30% did not intend to quit in the near future (precontemplation), 47% intended to quit in six months (contemplation), and 24% were preparing to quit in the next month.
In multivariate regression models adjusting for age, sex, race-ethnicity, income, education, hospital site (academic versus community), and cigarette dependence, poorer perceived general medical health (SF-12) was associated with contemplating and preparing to quit and greater desire to quit but also with greater cigarette dependence and anticipated difficulty quitting permanently (range of β=.07–.13, p<.05 for all). Poorer mental health functioning (SF-12) and greater severity of symptoms (BASIS-24) were associated with contemplating and preparing to quit and greater desire and expected success with quitting but also with greater tobacco dependence and anticipated difficulty quitting permanently (range of β=.08–.12, p<.05 for all) [see table in online data supplement].
Findings indicate that perceived symptoms did not hinder and may instead have motivated smoking cessation. Poorer perceived general medical health and more severe psychiatric symptoms were associated with greater motivation to quit. Although statistically significant and consistent, associations were weak, accounting for .7%−3.0% of the variance in tobacco dependence and readiness to quit.
A recent meta-analysis concluded that quitting smoking is associated with reductions in depression, anxiety, and stress and improvements in mood and quality of life among persons with and without psychiatric disorders (5). Clinicians are a critical resource in addressing tobacco-related disparities in psychiatric populations and can improve cessation success rates by building patient confidence and informing patients that quitting can improve both general medical and mental health.

Supplementary Material

File (appi.ps.201400181.ds001.pdf)

References

1.
Physician Behavior and Practice Patterns Related to Smoking Cessation. Washington, DC, Association of American Medical Colleges, 2007
2.
Prochaska JJ, Fletcher L, Hall SE, et al: Return to smoking following a smoke-free psychiatric hospitalization. American Journal on Addictions 15:15–22, 2006
3.
Siru R, Hulse GK, Khan RJK, et al: Motivation to quit smoking among hospitalised individuals with and without mental health disorders. Australian and New Zealand Journal of Psychiatry 44:640–647, 2010
4.
How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, Ga, Centers for Disease Control and Prevention, 2010. Available at www.cdc.gov/tobacco/data_statistics/sgr/
5.
Taylor G, McNeill A, Girling A, et al: Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (Epub ahead of print, Feb 13, 2014)

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Breakfast in the Garden, by Frederick Carl Frieseke, circa 1911. Oil on canvas, 26 x 325/16 inches. Daniel J. Terra Collection, 1987.21. Terra Foundation for American Art, Chicago/Art Resource, New York City.

Psychiatric Services
Pages: 443 - 444
PubMed: 25828988

History

Received: 29 April 2014
Revision received: 11 December 2014
Accepted: 22 January 2015
Published online: 1 April 2015
Published in print: April 01, 2015

Authors

Affiliations

Nicole Anzai, B.S.
Ms. Anzai and Dr. Prochaska are with the Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California. Dr. Young-Wolff is with the Division of Research, Kaiser Permanente, Oakland, California. Results were presented at the annual meeting of the Society of Behavioral Medicine, San Francisco, March 20–23, 2013.
Kelly C. Young-Wolff, Ph.D., M.P.H.
Ms. Anzai and Dr. Prochaska are with the Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California. Dr. Young-Wolff is with the Division of Research, Kaiser Permanente, Oakland, California. Results were presented at the annual meeting of the Society of Behavioral Medicine, San Francisco, March 20–23, 2013.
Judith J. Prochaska, Ph.D., M.P.H.
Ms. Anzai and Dr. Prochaska are with the Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California. Dr. Young-Wolff is with the Division of Research, Kaiser Permanente, Oakland, California. Results were presented at the annual meeting of the Society of Behavioral Medicine, San Francisco, March 20–23, 2013.

Competing Interests

Dr. Prochaska has received fees for serving as an expert witness against tobacco companies in several lawsuits. The other authors report no financial relationships with commercial interests.

Funding Information

National Institute of Mental Health10.13039/100000025: R01 MH083684
National Institute on Drug Abuse10.13039/100000026: P50 DA009253
This research was supported by grant R01 MH083684 from the National Institute of Mental Health and grant P50 DA009253 from the National Institute on Drug Abuse.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share